Sustained release preparations
AssigneeTakeda Chemical Industries, Ltd.
InventorsYohko Akiyama, Hidetoshi Horibe, Minoru Yoshioka
Life of this patent
Estimating the term…
Abstract
There is provided a matrix preparation produced by dispersing a pharmaceutically active ingredient into a matrix which is solid at ambient temperature and comprised of a fatty acid ester of a polyglycerol. The preparation has stable release controlling ability, can be processed to fine granules, granules, capsules, tablets etc., and contributes to reduction of the administration times of the active ingredient and side effects of the ingredient.
Claims16
Fine granules or granules which comprise a pharmaceutically active acidic ingredient and a water-insoluble or slightly water-soluble solid base having a particle size of not more than 50 .mu.m in a proportion of 1 to 80 weight %, dispersed into a matrix, wherein said matrix is solid at ambient temperature and contains a fatty acid ester of polyglycerol, said active acidic ingredient being contained in a proportion of 0.005 to 75 weight % said fine granules being composed of not less than 75 weight % of particles of 500 to 10 .mu.m, not more than 5 weight % of particles of not less than 500 .mu.m and not more than 10 weight % of particles of not more than 10 .mu.m and said granules being composed of not less than 90 weight % of particles of 1410 to 500 .mu.m and not more than 5 weight % of particles of not more than 177 .mu.m.
Fine granules or granules which comprise a pharmaceutically active basic ingredient and an enteric substance having a particle size of not more than 50 .mu.m in a proportion of 1 to 80 weight % dispersed into a matrix, wherein said matrix is solid at ambient temperature and contains a fatty acid ester of a polyglycerol, said active basic ingredient contained in a proportion of 0,005 to 75 weight %, said fine granules being composed of not less than 75 weight % of particles of 500 to 10 .mu.m, not more than 5 weight % of particles of not less than 500 .mu.m and not more than 10 weight % of particles of not more than 10 .mu.m and said granules being composed of not less than 90 weight % of particles of 1410 to 500 .mu.m and not more than 5 weight % of particles of not more than 177 .mu.m.
A tablet which is produced by tabletting fine granules or granules which comprise a pharmaceutically active ingredient dispersed into a matrix which is solid at ambient temperature and contains a fatty acid ester of a polyglycerol, the ester being present throughout the fine granules or granules, said fine granules being composed of not less than 75 weight % of particles of 500 to 10 .mu.m, not more than 5 weight % of particles of not less than 500 .mu.m and not more than 10 weight % of particles of not more than 10 .mu.m and said granules being composed of not less than 90 weight % of particles of 1410 to 500 .mu.m and not more than 5 weight of particles of not more than 177 .mu.m.
A tablet which is produced by tabletting fine granules or granules which comprise a pharmaceutically active ingredient dispersed into a matrix which is solid at ambient temperature and contains a fatty acid ester of a polyglycerol, the ester being present throughout the fine granules or granules, said fine granules being composed of not less than 75 weight % of particles of 500 to 10 .mu.m, not more than 5 weight % of particles of not less than 500 .mu.m and not more than 10 weight % of particles of not more than 10 .mu.m and said granules being composed of not less than 90 weight % of particles of 1410 to 500 .mu.m and not more than 5 weight % of particles of not more than 177 .mu.m, wherein the fine granules or granules are coated with a coating agent.
Dependencies are inferred from the claim text.